Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
Aschenbrenner, Diane S. MS, APRN-BC
Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD.
She also coordinates Drug Watch: firstname.lastname@example.org.
* The FDA is warning consumers to be wary of Web sites that advertise pandemic (H1N1) 2009 (swine flu) products that could be fraudulent or ineffective.
Almost immediately after the first cases of viral infection with pandemic (H1N1) 2009 (swine flu; formerly known as influenza A [H1N1]) were identified, certain Web sites, taking advantage of widespread public concern, began to offer a wide variety of products purported to diagnose, prevent, treat, mitigate, or cure the disease. The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) warn that such sites may be advertising fraudulent drug products misrepresented as antivirals, and others may be offering dietary supplements or other products for the prevention and treatment of the virus that, in fact, have no known effect on the disease.
According to an FDA news release from May 1 (http://bit.ly/4FHNo), such products will not "prevent the transmission of the virus or offer effective treatments against infections caused by the H1N1 influenza virus" and may be ineffective or unsafe. One of the sites identified (www.noswineflu.com) offers a "swine flu prevention guide" that provides links for the purchase of herbs and dietary remedies it claims will prevent the disease. Another such site (http://bit.ly/sVpxv) sells probiotic supplements it claims can prevent both pandemic (H1N1) 2009 infection and avian flu (H5N1). The FDA and the FTC will take regulatory or criminal action against offending sites that don't correct or remove such promotions. At present, the agency has approved two antiviral drugs, Tamiflu (oseltamivir) and Relenza (zanamivir), for the prevention and treatment of the pandemic (H1N1) 2009 virus. Nurses should tell their patients about information available from the FDA on the safe purchase of medication online (see http://bit.ly/PHiFX). For more information on FDA-approved antiviral drugs and the Centers for Disease Control and Prevention's recommendations regarding the use of them for H1N1, go to http://bit.ly/2p0K64 and http://bit.ly/wjLtm, respectively.
© 2009 Lippincott Williams & Wilkins, Inc.
Colleague's E-mail is Invalid
Your Name: (optional)
Separate multiple e-mails with a (;).
Thought you might appreciate this item(s) I saw at AJN The American Journal of Nursing.
Send a copy to your email
Your message has been successfully sent to your colleague.
Some error has occurred while processing your request. Please try after some time.
An Existing Folder
A New Folder
The item(s) has been successfully added to "".
Login with your LWW Journals username and password.
Username or Email:
Enter and submit the email address you registered with. An email with instructions to reset your password will be sent to that address.
Link to reset your password has been sent to specified email address.
What does "Remember me" mean?
By checking this box, you'll stay logged in until you logout. You'll get easier access to your articles, collections,
media, and all your other content, even if you close your browser or shut down your
To protect your most sensitive data and activities (like changing your password),
we'll ask you to re-enter your password when you access these services.
What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend
that you uncheck the "Remember me" box.
Save my selection
Article Level Metrics